Pregled bibliografske jedinice broj: 1100955
Azithromycin: Single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome- A randomized study
Azithromycin: Single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome- A randomized study // Infection, 27 (1999), 3; 198-202 doi:10.1007/BF02561528 (međunarodna recenzija, članak, ostalo)
CROSBI ID: 1100955 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Azithromycin: Single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome- A randomized study
Autori
Sch0nwald, S ; Kuzman, I: Oreskovic, K ; Burek, V ; Skerk, V ; Car, V ; Bozinovic.D ; Culig, J ; Radosevic, S
Izvornik
Infection (0300-8126) 27
(1999), 3;
198-202
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
azithromycin, single dose, atypical pneumonia syndrome, randomized study
Sažetak
A total of 100 adult patients with atypical pneumonia syndrome were randomized to receive 1.5 mg of azithrimycin as a single dose or 500 mg once daily for 3 days. In conclusion, a single 1.5 g dose of azithromycin may be an alternative to standard 3.day azithromycin regimen in the treatment of outpatients with atypical pneumonia syndrome.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Veleučilište Velika Gorica
Profili:
Senka Radošević
(autor)
Josip Čulig
(autor)
Vitomir Burek
(autor)
Višnja Škerk
(autor)
Vladimir Car
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE